Contraception
Volume 73, Issue 5 , Pages 501-506 , May 2006

Agreement between women's and providers' assessment of hormonal contraceptive risk factors

  • Solmaz Shotorbani

      Affiliations

    • Department of Pharmacy, The University of Washington, Box 357630, Seattle, WA 98195, USA
    • ,
  • Leslie Miller

      Affiliations

    • Department of Obstetrics and Gynecology, The University of Washington, Seattle, WA 98195, USA
    • ,
  • David K. Blough

      Affiliations

    • Department of Pharmacy, The University of Washington, Box 357630, Seattle, WA 98195, USA
    • ,
  • Jacqueline Gardner

      Affiliations

    • Department of Pharmacy, The University of Washington, Box 357630, Seattle, WA 98195, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 206 685 4128; fax: +1 206 543 3835.

Received 11 November 2005 ,Revised 15 December 2005 ,Accepted 16 December 2005.

References 

  1. Stewart FH, Harper CC, Ellertson CE, Grimes DA, Sawaya GF, Trussell J. Clinical breast and pelvic examination requirements for hormonal contraception: current practice vs evidence. JAMA. 2001;285(17):2232–2239
  2. World Health Organization . Medical eligibility criteria for initiating and continuing use of contraceptive methods. 3rd ed.. Geneva (Switzerland): WHO; 2004;
  3. Hatcher RA, Nelson A. Combined hormonal contraceptive methods. In:  Trussell J,  Stewart F,  Nelson A, et al. editor. Contraceptive technology. 18th ed. New York: Ardent Media, Inc; 2004;p. 412
  4. International Planned Parenthood Federation . In: Medical and service delivery guidelines for sexual and reproductive health services. 3rd ed.. United Kingdom: London; 2004;p. 86
  5. Harper C, Balistreri E, Boggess J, Leon K, Darney P. Provision of hormonal contraceptives without a mandatory pelvic examination: the first stop demonstration project. Fam Plann Perspect. 2001;3:13–18
  6. Stang A, Schwingl P, Rivera R. New contraceptive eligibility checklists for provision of combined oral contraceptives and depot-medroxyprogesterone acetate in community-based programmes. Bull WHO. 2000;78:1015–1023
  7. Hannaford PC, Webb AM. Evidence-guided prescribing of combined oral contraceptives: consensus statement. An International Workshop at Mottram Hall, U.K. Wilmslow, March, 1996. Contraception. 1996;54:125–129
  8. Family Health International . Provider checklists for reproductive health services: reference guide. Available at: http://www.fhi.org/en/RH/Pubs/servdelivery/checklists/index.htm[Retrieved May 23, 2005]
  9. Shotorbani S, et al. Contraceptive prescribing by community pharmacists: the direct access Study. [Abstract] Contraception. 2004;70:258
  10. Hobbs SD, Wilmink AB, Adam DJ, Bradbury AW. Assessment of smoking status in patients with peripheral arterial disease. J Vasc Surg. 2005;4:451–456
  11. Hald J, Overgaard J, Grau C. Evaluation of objective measures of smoking status — a prospective clinical study in a group of head and neck cancer patients treated with radiotherapy. Acta Oncol. 2003;42:154–159
  12. Caraballo RS, Giovino GA, Pechacek TF. Self-reported cigarette smoking vs. serum cotinine among U.S. adolescents. Nicotine Tob Res. 2004;6:19–25
  13. Bosetti C, Tavani A, Negri E, Trichopoulos D, La Vecchia C. Reliability of data on medical conditions, menstrual and reproductive history provided by hospital controls. J Clin Epidemiol. 2001;54:902–906
  14. Bean JA, Leeper JD, Wallace RB, Sherman BM, Jagger H. Variations in the reporting of menstrual histories. Am J Epidemiol. 1979;109:181–185
  15. Lipton RB, Amatniek JC, Ferrari MD, Gross M. Migraine. Identifying and removing barriers to care. Neurology. 1994;44(Suppl 4):S63–S68
  16. Marcus DA, Kapelewski C, Jacob RG, Rudy TE, Furman JM. Validation of a brief nurse-administered migraine assessment tool. Headache. 2004;44:328–332
  17. MacGregor EA. Hormonal contraception and migraine. J Fam Plann Reprod Health Care. 2001;27:49–52
  18. United States Census Bureau . Washington quick facts. Available at: http://quickfacts.census.gov/qfd/states/53/53033.html[Retrieved July 18, 2005]
  19. Mosher WD, Martinez GM, Chandra A, Abma JC, Willson SJ. Use of contraception and use of family planning services in the United States: 1982–2002. Adv Data. 2004;(350):1–36
  20. Potts M, Denny C. Safety implications of transferring the oral contraceptive from prescription-only to over-the-counter status. Drug Saf. 1995;13:333–337
  21. Harrison-Woolrych M, Howe J, Smith C. Improving access to emergency contraception. BMJ. 2001;322:186–187
  22. Trussell J, Stewart F, Potts M, Guest F, Ellertson C. Should oral contraceptives be available without prescription?. Am J Publ Health. 1993;83:1094–1098
  23. Guendelman S, Denny C, Mauldon J, Chetkovich C. Perceptions of hormonal contraceptive safety and side effects among low-income Latina and non-Latina women. Matern Child Health J. 2000;4:233–239
  24. Miller L, Nielsen C. Internet availability of contraceptives. Obstet Gynecol. 2001;97:121–126
  25. Colditz GA, Martin P, Stampfer MJ, et al. Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women. Am J Epidemiol. 1986;123:894–900
  26. Goodman MT, Nomura AM, Wilkens LR, Kolonel LN. Agreement between interview information and physician records on history of menopausal estrogen use. Am J Epidemiol. 1990;131:815–825
  27. Boissonnault WG, Badke MB. Collecting health history information: the accuracy of a patient self-administered questionnaire in an orthopedic outpatient setting. Phys Ther. 2005;85:531–543
  28. Papageorghiou AT, Yu CK, Erasmus IE, Cuckle HS, Nicolaides KH. Assessment of risk for the development of pre-eclampsia by maternal characteristics and uterine artery Doppler. BJOG. 2005;112:703–709

PII: S0010-7824(05)00479-8

doi: 10.1016/j.contraception.2005.12.001

Contraception
Volume 73, Issue 5 , Pages 501-506 , May 2006

Article Tools